New Delhi, 07th July 2025: Aerolase, a global technology leader in Laser skin health, has taken a significant step forward in the Indian market with the launch of its US FDA-approved Neo Elite laser treatment in collaboration with Kaya, a leading dermatology chain clinic in India. The treatment will now be available across all Kaya clinics nationwide, signifying a major leap forward in non-invasive skincare for Indian consumers. As a pioneer in global skincare innovation, Aerolase is empowering Indian consumers by making advanced, research-driven treatments available and customizable for the diverse needs of Indian skin.
Acne is one of the most common dermatologic conditions worldwide, with a global prevalence estimated at approximately 9–10% based on Global Burden of Disease (GBD) data. Traditional acne treatments, oral medications, creams, and hormone therapies require prolonged use. This has led to the rise in demand for non-invasive, effective solutions with minimal or no downtime and discomfort
Underscoring the market need for this innovation, voiced Mr. Madhusudhan HK, Country Manager, Aerolase. India’s dermatology and aesthetic market is among the fastest-growing globally, projected to grow at a CAGR of 10.11% from 2025 to 2032. Aerolase’s collaboration with Kaya is perfectly timed to meet India’s rising demand by innovations such as 650 microsecond breakthrough technology for safer, customizable treatments. Within this rapidly advancing landscape, Neo Elite’s technology stands out by not overheating surrounding skin or causing pigmentation issues. Its contactless design ensures optimal hygiene, making it ideal for those with acne-prone skin. The device effectively addresses active acne, post-inflammatory hyperpigmentation, and redness in the same session, minimizing the need for multiple treatments. Its versatility means it can treat a range of concerns, from teenage Acne to adult acne and postpartum breakouts, and can be safely integrated with existing skincare routines.”
Aerolase has collaborated with Kaya to bring its advanced laser technology to a broader patient base. Supported by extensive global clinical evidence, Aerolase offers reliable, reproducible outcomes across 36 indications from aesthetic procedures to complex dermatological conditions. By integrating with Kaya’s wide-ranging expertise, the collaboration aims to enhance access to comprehensive, science-driven skin and beauty solutions.
Reflecting on the significance of this development, Nishant Nayyar, Marketing Head and VP, shared, “Our collaboration with Aerolase brings globally trusted laser technology to India, marking a new era in advanced acne care. The Neo Elite’s laser, which is exclusive amongst all chain clinics in India offers a safer, effective solution for all skin types, including sensitive, with no downtime. This partnership reflects Kaya’s commitment to making world-class, dermatologist-led treatments more accessible and results-driven for today’s consumer.”
Dr Priya Puja, Head Dermatologist (North & East), Kaya Clinic, said, “With the introduction of the Aerolase Neo Elite, we’re seeing a paradigm shift in how we treat acne and related skin concerns in India. This technology allows us to offer highly effective, non-invasive treatments that are gentle on sensitive and all skin tones, something that conventional therapies often fall short of. It’s a significant advancement that aligns with Kaya’s commitment to personalized, safe, and evidence-based dermatological care.”
With this innovative approach, sessions last just 20–30 minutes and have no downtime; the treatment is tailored for busy lifestyles. Every procedure at Kaya is supervised by expert dermatologists, ensuring precise assessment and customized care.
With the launch of Aerolase Neo Elite, the new treatment would be an opportunity for modern Indian consumers seeking fast, effective, dermatologist-backed acne solutions. This collaboration sets a new benchmark for advanced dermatological care in India, making globally trusted care accessible for all.